The MTHFR promoter hypermethylation pattern associated with the A1298C polymorphism influences lipid parameters and glycemic control in diabetic patients-Reference-Cited by-同舟云学术

The MTHFR promoter hypermethylation pattern associated with the A1298C polymorphism influences lipid parameters and glycemic control in diabetic patients

Published:2019-01-15 Issue:1 Volume:11 Page:
ISSN:1758-5996
Container-title:Diabetology & Metabolic Syndrome
language:en
Short-container-title:Diabetol Metab Syndr

Author:

Santana Bezerra Herlanny^ORCID,Severo de Assis Caroline^ORCID,dos Santos Nunes Mayara Karla^ORCID,Wanderley de Queiroga Evangelista Isabella^ORCID,Modesto Filho João^ORCID,Alves Pegado Gomes Cecília Neta^ORCID,Ferreira do Nascimento Rayner Anderson^ORCID,Pordeus Luna Rafaella Cristhine^ORCID,de Carvalho Costa Maria José^ORCID,de Oliveira Naila Francis Paulo^ORCID,Camati Persuhn Darlene^ORCID

Funder

Fundação de Apoio à Pesquisa do Estado da Paraíba

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1186/s13098-019-0399-9.pdf

Reference28 articles.

1. Satyanarayana A, Balakrishna N, Pitla S, et al. Status of B-vitamins and homocysteine in diabetic retinopathy: association with vitamin-B12 deficiency and hyperhomocysteinemia. PLoS ONE. 2011;6(11):e26747.

2. Li Y, Zhang H, Jiang C, et al. Hyperhomocysteinemia promotes insulin resistance by inducing endoplasmic reticulum stress in adipose tissue. J Biol Chem. 2013;288(14):9583–92.

3. Buysschaert M, Dramais AS, Wallemacq PE, Hermans MP. Hyperhomocysteinemia in type 2 diabetes: relationship to macroangiopathy, nephropathy, and insulin resistance. Diabetes Care. 2000;23(12):1816–22.